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Background
Thoracic aortic aneurysm (TAA) disease is an often
asymptomatic, insidious process that includes structural
aortic changes, dilation, and eventually causes death.
Aneurysm prevalence exceeds 4% and is the 15th
leading cause of death in the US. TAA disease is asso-
ciated with congenital and acquired defects in the
aortic wall including elastin derangements, increased
collagen, glycosaminolycan/proteoglycan accumulation,
and loss of smooth muscle cells. We aim to investigate
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Figure 1 A) Normal colloidal iron stained aortic media at 10x magnification. B and C) Pre- and post-gadolinium proximal descending aortic wall
in a control patient demonstrating minimal gadolinium uptake, change in SNR 7%, CNR 11% D) colloidal iron stain demonstrating severe medial
myxoid degeneration in a patient with Marfan syndrome, 10x magnification. E and F) Pre- and post-gadolinium proximal descending aortic wall
in a Marfan syndrome patient, demonstrating increased gadolinium uptake, change in SNR 43%, CNR 88%.
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these changes non-invasively by studying the uptake of
gadolinium (Gd) in the diseased aortic wall. The distri-
bution and accumulation of Gd depends on tissue
blood flow, the size of the interstitial space, and
permeability of capillaries, and has potential to help
characterize severity of TAA disease.
Methods
We recruited patients undergoing cardiac MR or thoracic
MRA for clinical care at Stanford University Hospital on a
1.5T GE scanner. We imaged a cross-section of the
thoracic aorta before and after Gd administration, using
T1-weighted double inversion recovery in 9 patients, 5
with connective tissue disease (e.g. Marfan syndrome) and
4 controls. We used a small field of view, 18 cm, with
matrix size 512 x 224, echo train length 16, slice thickness
8 mm, 2 R-R intervals, ECG-gating and breath-holding
were used, with a 30 second acquisition. The post-Gd
images were acquired 5-7 minutes after injection. For each
segment of aorta imaged, SNR and CNR were calculated
for the aortic wall before and after contrast (CNR was
calculated vs. lumen using a 7-10 mm2 region-of interest
(ROI) in the wall and 50-55 mm2 ROI in the lumen, as in
Figure 1.
Results
We found significant post-Gadolinium enhancement of
the aortic wall (7.0 +/- 2.9 absolute increase in SNR, 7.6
+/- 4.4 increase in CNR) in patients with aneurysms and
connective tissue disease (Figure 2). By comparison,
control patients had minimal evidence of Gd uptake
(-0.7 +/- 3.1 decrease in SNR, -0.3 +/- 2.5 decrease in
CNR). P < 0.05 for SNR and CNR comparisons in patients
versus controls.
Conclusions
Significant aortic wall Gd enhancement is seen in patients
with connective tissue diseases and aneurysm formation
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Figure 2 Comparison of SNR and CNR between patients and controls. Central box = 25-75 percentile, middle line = median. Whiskers = range.
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